Chinese Journal of Dermatology ›› 2025, Vol. 58 ›› Issue (6): 503-507.doi: 10.35541/cjd.20240719
• Expert Commentary • Previous Articles Next Articles
Song Zhiqiang, Yang Xianjie, Chen Qiquan
Received:
2024-12-27
Revised:
2025-01-13
Online:
2025-06-15
Published:
2025-06-03
Contact:
Song Zhiqiang
E-mail:drsongzq@tmmu.edu.cn
Song Zhiqiang, Yang Xianjie, Chen Qiquan. Disease management and modification in chronic spontaneous urticaria: needs and prospects in the new era[J]. Chinese Journal of Dermatology, 2025, 58(6): 503-507.doi:10.35541/cjd.20240719
[1] | Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria[J]. Allergy, 2022,77(3):734⁃766. doi: 10.1111/all. 15090. |
[2] | Kolkhir P, Bonnekoh H, Metz M, et al. Chronic spontaneous urticaria: a review[J]. JAMA, 2024,332(17):1464⁃1477. doi: 10.1001/jama.2024.15568. |
[3] | Zuberbier T, Ensina LF, Giménez⁃Arnau A, et al. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment[J]. Lancet, 2024,404(10450):393⁃404. doi: 10.1016/S0140⁃6736(24)00852⁃3. |
[4] | Lang DM, Sheikh J, Joshi S, et al. Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: evolving toward personalized medicine[J]. Ann Allergy Asthma Immunol, 2025,134(4):408⁃417. doi: 10.1016/j.anai.2024.10.026. |
[5] | Sánchez J, Amaya E, Acevedo A, et al. Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors[J]. J Allergy Clin Immunol Pract, 2017,5(2):464⁃470. doi: 10.1016/j.jaip.2016.09.029. |
[6] | Chen Q, Yang X, Ni B, et al. Atopy in chronic urticaria: an important yet overlooked issue[J]. Front Immunol, 2024,15:1279976. doi: 10.3389/fimmu.2024.1279976. |
[7] | Kolkhir P, Borzova E, Grattan C, et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review[J]. Autoimmun Rev, 2017,16(12):1196⁃1208. doi: 10.1016/j.autrev.2017.10.003. |
[8] | Sella JA, Ferriani M, Melo J, et al. TypeⅠ and typeⅡb autoimmune chronic spontaneous urticaria: using common clinical tools for endotyping patients with CSU[J]. J Allergy Clin Immunol Glob, 2023,2(4):100159. doi: 10.1016/j.jacig. 2023.100159. |
[9] | Elieh⁃Ali⁃Komi D, Metz M, Kolkhir P, et al. Chronic urticaria and the pathogenic role of mast cells[J]. Allergol Int, 2023,72(3):359⁃368. doi: 10.1016/j.alit.2023.05.003. |
[10] | Larenas⁃Linnemann D. Biomarkers of autoimmune chronic spontaneous urticaria[J]. Curr Allergy Asthma Rep, 2023,23(12):655⁃664. doi: 10.1007/s11882⁃023⁃01117⁃7. |
[11] | Schoepke N, Asero R, Ellrich A, et al. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST study[J]. Allergy, 2019,74(12):2427⁃2436. doi: 10.1111/all.13949. |
[12] | Altrichter S, Fok JS, Jiao Q, et al. Total IgE as a marker for chronic spontaneous urticaria[J]. Allergy Asthma Immunol Res, 2021,13(2):206⁃218. doi: 10.4168/aair.2021.13.2.206. |
[13] | 中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2022版)[J]. 中华皮肤科杂志, 2022,55(12):1041⁃1049. doi: 10.35541/cjd.20220609. |
[14] | Buttgereit T, Salameh P, Sydorenko O, et al. The 7⁃day recall period version of the urticaria control test⁃UCT7[J]. J Allergy Clin Immunol, 2023,152(5):1210⁃1217. doi: 10.1016/j.jaci. 2023.03.034. |
[15] | Cherrez⁃Ojeda I, Bousquet J, Giménez⁃Arnau A, et al. Patient⁃reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice[J]. J Allergy Clin Immunol Pract, 2024,12(6):1575⁃1583. doi: 10.1016/j.jaip. 2024.03.050. |
[16] | Bernstein JA, Apfelbacher C, Chu DK, et al. Patient⁃reported outcome measures in chronic spontaneous urticaria, angioedema, and atopic dermatitis[J]. J Allergy Clin Immunol Pract, 2024,12(10):2583⁃2590. doi: 10.1016/j.jaip.2024.08.021. |
[17] | Neisinger S, Sousa Pinto B, Ramanauskaite A, et al. CRUSE® ⁃an innovative mobile application for patient monitoring and management in chronic spontaneous urticaria[J]. Clin Transl Allergy, 2024,14(1):e12328. doi: 10.1002/clt2.12328. |
[18] | Sousa⁃Pinto B, Ramanauskaite A, Neisinger S, et al. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: a CRUSE® mobile health study[J]. Allergy, 2025,80(3):750⁃761. doi: 10.1111/all.16371. |
[19] | Carvallo A, Veleiro B, Sabaté⁃Brescó M, et al. Serum amyloid A as a potential biomarker for disease activity in chronic spontaneous urticaria[J]. J Allergy Clin Immunol Pract, 2024,12(1):195⁃200. doi: 10.1016/j.jaip.2023.09.004. |
[20] | Jian X, Hou G, Li L, et al. Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria[J]. J Allergy Clin Immunol, 2024,154(2):412⁃423. doi: 10.1016/j.jaci.2024.01.032. |
[21] | Ridge K, Moran B, Alvarado⁃Vazquez PA, et al. Lin-CD117+ |
CD34+FcεRⅠ + progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti⁃IgE therapy[J]. Allergy, 2024,79(9):2423⁃2434. doi: 10.1111/all.16127. | |
[22] | Ji J, Tang M, Zhao Y, et al. In chronic spontaneous urticaria, increased galectin⁃9 expression on basophils and eosinophils is linked to high disease activity, endotype⁃specific markers, and response to omalizumab treatment[J]. Allergy, 2024,79(9):2435⁃2447. doi: 10.1111/all.16239. |
[23] | Maurer M, Augustin M, Bauer S, et al. Modelling of patient journey in chronic spontaneous urticaria: increasing awareness and education by shorten patients' disease journey in Germany[J]. J Eur Acad Dermatol Venereol, 2024,38(11):2093⁃2101. doi: 10.1111/jdv.19940. |
[24] | Yuasa A, Yonemoto N, Kamei K, et al. Systematic literature review of the use of productivity losses/gains in cost⁃effectiveness analyses of immune⁃mediated disorders[J]. Adv Ther, 2022,39(12):5327⁃5350. doi: 10.1007/s12325⁃022⁃02321⁃z. |
[25] | Nochaiwong S, Chuamanochan M, Ruengorn C, et al. Cost and cost⁃effectiveness of the management strategies of chronic urticaria: a systematic review[J]. JAMA Dermatol, 2024,160(11):1225⁃1236. doi: 10.1001/jamadermatol.2024.2863. |
[26] | Kaplan A, Lebwohl M, Giménez⁃Arnau AM, et al. Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances[J]. Allergy, 2023,78(2):389⁃401. doi: 10. 1111/all.15603. |
[27] | Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges[J]. Nat Rev Drug Discov, 2023,22(8):662⁃680. doi: 10.1038/s41573⁃023⁃00735⁃0. |
[28] | Jacobson ME, Seshadri RS, Morimoto R, et al. Early intervention and disease modification in atopic dermatitis⁃the current state of the field and barriers to progress[J]. J Eur Acad Dermatol Venereol, 2024,38(4):665⁃672. doi: 10.1111/jdv.19699. |
[29] | Maurer M, Kolkhir P, Pereira MP, et al. Disease modification in chronic spontaneous urticaria[J]. Allergy, 2024,79(9):2396⁃2413. doi: 10.1111/all.16243. |
[30] | Tharp MD, Bernstein JA, Kavati A, et al. Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta⁃analysis of "real⁃world" evidence[J]. JAMA Dermatol, 2019,155(1):29⁃38. doi: 10.1001/jamadermatol.2018.3447. |
[31] | Maurer M, Ensina LF, Gimenez⁃Arnau AM, et al. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials[J]. Lancet, 2024,403(10422):147⁃159. doi: 10.1016/S0140⁃6736(23)01684⁃7. |
[32] | Maurer M, Casale TB, Saini SS, et al. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY⁃CSU CUPID): two randomized, double⁃blind, placebo⁃controlled, phase 3 trials[J]. J Allergy Clin Immunol, 2024,154(1):184⁃194. doi: 10.1016/j.jaci.2024.01.028. |
[33] | Grattan C, Kocatürk E. How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab[J]. Br J Dermatol, 2024,191(2):153⁃154. doi: 10.1093/bjd/ljae165. |
[34] | Jain V, Giménez⁃Arnau A, Hayama K, et al. Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks[J]. J Allergy Clin Immunol, 2024,153(2):479⁃486. doi: 10.1016/j.jaci.2023. 10.007. |
[35] | Min TK, Saini SS. The future of targeted therapy in chronic spontaneous urticaria[J]. Ann Allergy Asthma Immunol, 2024,133(4):367⁃373. doi: 10.1016/j.anai.2024.05.020. |
[36] | Metz M, Kolkhir P, Altrichter S, et al. Mast cell silencing: a novel therapeutic approach for urticaria and other mast cell⁃mediated diseases[J]. Allergy, 2024,79(1):37⁃51. doi: 10.1111/all.15850. |
[1] | Li Enze, Chen Lu, Zhang Chuqiao, Yao Yuxu, Jiao Qingqing, Ji Jiang. Correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 577-581. |
[2] | Qi-Quan CHEN Song Zhi-Qiang WANG Gang. Guidelines for the diagnosis and treatment of refractory chronic spontaneous urticaria in China (2025 edition) [J]. Chinese Journal of Dermatology, 2025, 58(6): 485-496. |
[3] | Tang Huiyang, Yang Zhi, Yang Xi, Yao Zhengqiu, Hao Fei, Chen Bangtao. Mechanistic studies on the involvement of trimethylamine oxide in the pathogenesis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 515-522. |
[4] | Huang Xuewei, Chen Qiquan, Yang Xianjie, Chen Anqi, Wang Huan, Deng Sisi, Zhai Zhifang, Wang Juan, Song Zhiqiang . Comparisons of clinical and pathological characteristics of urticarial vasculitis versus chronic spontaneous urticaria with pigmentation [J]. Chinese Journal of Dermatology, 2025, 58(6): 508-514. |
[5] | Xiao Meng, Zhao Meiru, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping. Disease burden in patients with chronic spontaneous urticaria: a single-center retrospective analysis [J]. Chinese Journal of Dermatology, 2025, 58(6): 530-535. |
[6] | Liang Bihua, Chen Ziyan, Li Huaping, Zou Hui, Lin Tianyi, Li Xiaofeng, Zhang Luoyu, Li Shengxin, Ou Shanshan, Chen Jiaoquan, Li Runxiang, Zhu Huilan. Analysis of serum inflammatory factors associated with antihistamine resistance in patients with chronic spontaneous urticaria using the Olink-targeted proteomics technology [J]. Chinese Journal of Dermatology, 2025, 58(6): 523-529. |
[7] | Zhao Meiru, Xiao Meng, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping. Omalizumab for the treatment of eight patients with chronic spontaneous urticaria during pregnancy and lactation [J]. Chinese Journal of Dermatology, 2025, 58(6): 536-539. |
[8] | He Zezhi, Chen Jiazhen, Wu Hui, Shen Haojia, Zhu Huilan, Li Runxiang. Trends in urticaria incidence and its association with air pollutants among children aged 0 - 14 years in China from 1990 to 2021: a multi-model analysis [J]. Chinese Journal of Dermatology, 2025, 58(6): 540-545. |
[9] | Qiu Li, Xiao Ting . Bruton′s tyrosine kinase inhibitors in the treatment of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 563-567. |
[10] | Liang Gaopeng, Yang Xianjie, Chen Qiquan, Song Zhiqiang. Comorbidities of chronic urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 567-572. |
[11] | Zheng Yaxuan, Su Huichun. Role of sweat in the pathogenesis of cholinergic urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 573-577. |
[12] | Wang Weixia, Wang Chen, Dou Jinfa, Bian Lu, Song Jinghui, Li Zhenlu, Li Jianguo, Wang Jianbo. Hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis: case report and literature review of genotype-phenotype correlations [J]. Chinese Journal of Dermatology, 2025, 58(4): 356-360. |
[13] | Ye Mingyu, Shi Yanting, Li Hao, Xiang Jie, Wang Song, Cao Hua. Clinical significance of serum galectin-9 levels in the evaluation of combined tumors in dermatomyositis patients [J]. Chinese Journal of Dermatology, 2025, 58(4): 328-333. |
[14] | Ye Hui, Deng Shilin, Liang Jingyao, Zhang Xibao. Correlations between the control of atopic dermatitis recurrence and tissue-resident memory T cells [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240192-e20240192. |
[15] | Wang Xin, Liu Lijuan, Li Linfeng. Clinical features of physical urticaria: a multicenter hospital-based cross-sectional questionnaire survey in China [J]. Chinese Journal of Dermatology, 2024, 57(8): 693-697. |
|